La Jolla Institute Board of Directors elects two visionary business leaders
LA JOLLA, CA—The La Jolla Institute for Immunology is pleased to announce that Larry Spitcaufsky and Hunt Pettit have been
How to become a T follicular helper cell
LA JOLLA, CA—Follicular helper Tcells (TFH cells), a rare type of immune cell that is essential for inducing a strong
Genetic differences impact how people react to dengue
LA JOLLA, CA—Researchers at the La Jolla Institute (LJI) for Allergy and Immunology identified a unique subset of helper T
La Jolla Institute Board of Directors elects top business leader
LA JOLLA, CA—The La Jolla Institute for Immunology (LJI) is pleased to announce that visionary business leader Richard S. Bodman
La Jolla Institute welcomes new faculty member
LA JOLLA, CA—Pandurangan Vijayanand (Vijay), M.D., Ph.D., has been appointed to the position of associate professor in the Division of
A subpopulation of white blood cells guards against tumor lung metastasis
LA JOLLA, CA— One goal of immunotherapy is to rally a patient’s often over‐burdened immune cells to effectively attack a
The innate immune system modulates the severity of multiple sclerosis
LA JOLLA, CA—Multiple sclerosis, a debilitating neurological disease, is triggered by self-reactive T cells that successfully infiltrate the brain and
Macrophages, monocytes amplify neuroinflammation in multiple sclerosis